Among the FGFR3-related osteochondrodysplasias, research programs have been developed using Fgfr3 gene–targeted mouse models to provide mechanistic insights into ACH, with opportunities for therapy (14, 30). This evidence concerns the gene FGFR3 and osteochondrodysplasia.